Ignite Creation Date:
2025-12-25 @ 5:07 AM
Ignite Modification Date:
2026-06-05 @ 7:11 PM
Study NCT ID:
NCT06601127
Status:
RECRUITING
Last Update Posted:
2025-03-07
First Post:
2024-09-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Tiprogrel in the Treatment of High-risk Patients with Acute Ischemic Cerebrovascular Events (THRIVE).
Sponsor:
Tianjin Institute of Pharmaceutical Research Co., Ltd
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Ischemic Stroke | View |
Keywords: